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Abstract
Background: The aim of this study is to evaluate heart rate recovery (HRR) and association 
between coronary flow rate and HRR in patients with metabolic syndrome (MS) who had 
morphologically normal coronary angiogram.
Methods: Study population included 43 patients with MS and 37 control subjects without 
MS. All patients were selected from individuals who had recently undergone coronary an-
giography in our hospital and were diagnosed as having angiographically normal coronary 
arteries. Exercise stress test results obtained prior to coronary angiography were evaluated for 
calculating HRR and other parameters. In addition, coronary flow was objectively evaluated 
for each major coronary artery in each subject using TIMI frame count method.
Results: All HRR values calculated were detected significantly lower in MS group compared 
to controls (HRR first: 32 ± 9 vs. 37 ± 10; p = 0.01, second: 46 ± 11 vs. 52 ± 11; p = 0.03, 
third: 51 ± 12 vs. 59 ± 12; p = 0.00, fourth: 54 ± 13 vs. 61 ± 2; p = 0.02). TIMI frame 
counts for each major epicardial coronary artery and mean TIMI frame count were also found 
to be significantly higher in MS group compared to controls (left anterior descending artery: 
51 ± 24 vs. 39 ± 15; p = 0.009, left circumflex artery: 32 ± 11 vs. 24 ± 7; p = 0.001, right 
coronary artery: 33 ± 14 vs. 24 ± 10; p = 0.003, mean TIMI frame count: 38 ± 15 vs. 29 ± 9;  
p = 0.002). Additionally, significant negative correlations were also detected between HRR  
first minute and coronary TIMI frame count values in patients with MS. None of MS para-
meters did not affect HRR values, however mean TIMI frame count independently associated 
with HRR first minute (p = 0.04) in patients with MS.
Conclusions: Impaired coronary blood flow occurring in MS might be a clue of autonomic 
dysfunction in addition to previously known endothelial dysfunction. (Cardiol J 2014; 21, 3: 
257–264)
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Introduction
Heart rate recovery (HRR) is defined as the 
difference of heart rate (HR) at peak exercise and 
at a specific time interval following the onset of 
recovery. HRR appears to be related to the balance 
of sympathetic and parasympathetic tonus, which 
is mediated partly by the alterations in venous 
return and stretch of atrial receptors. The rise in 
HR during exercise is considered to be due to the 
combination of parasympathetic withdrawal and 
sympathetic activation. Therefore, HRR is a re-
flection of vagal reactivation and impaired HRR is 
considered to represent decreased vagal tone [1, 2]. 
Slow deceleration of HR after exercise was found to 
be an independent predictor of cardiovascular (CV) 
disease and all-cause mortality [3, 4]. Autonomic 
dysfunction, including impaired vagal reactivation, 
as well as sympathetic overactivity, is known to 
be associated with hyperinsulinemia or insulin 
resistance, which determines metabolic syndrome 
(MS) [5–7]. An association has been found between 
HRR and MS, as well as between HRR and each of 
the components of this syndrome [8, 9].
In patients at high risk for coronary artery 
disease (CAD), such as patients with MS, endo-
thelial dysfunction is observed even in morpholo-
gically intact vessels before the onset of clinically 
manifested vascular disease [10, 11]. It was also 
demonstrated that coronary flow rate was decrea-
sed in patients with MS [12]. The Thrombolysis in 
Myocardial Infarction (TIMI) frame count is a sim-
ple clinical tool for assessing quantitative indexes 
of coronary blood flow. It has been suggested that 
a higher TIMI frame count may reflect endothe-
lial dysfunction [13]. The effect of the autonomic 
nervous system on coronary blood flow and insulin 
resistance is well known, however, it has not been 
exactly established yet whether impaired coronary 
blood flow occurring in MS arises from endothelial 
dysfunction or autonomic dysfunction.
In this study, we aimed to evaluate HRR at 
various time intervals, and the association between 
coronary flow rate and HRR in patients with MS 
who had morphologically normal epicardial coro-
nary arteries in coronary angiography.
Method
Study population
The study population included 43 patients 
with MS (group I: 22 men, 21 women; mean age 
55 ± 10 years) and 37 control subjects without 
MS (group II: 22 men, 15 women; mean age 
51 ± 8 years). All patients were selected from the 
individuals who had recently undergone coronary 
angiography in our hospital with a suspicion of CAD 
and were diagnosed as having angiographically nor-
mal coronary arteries. The indications for coronary 
angiography in these patients were the presence of 
angina pectoris and/or abnormal noninvasive test 
results suggesting myocardial ischemia. Exercise 
stress test results of the patients obtained prior 
to the coronary angiography were evaluated for 
calculating HRR values and other parameters. 
Exclusion criteria included known CAD, history 
of myocardial infarction, left ventricular dysfun-
ction, left ventricular hypertrophy, valvular heart 
disease, an implanted pacemaker, atrial fibrillation, 
hypo-hyperthyroidism, uncontrolled hypertension, 
and chronic respiratory disease. The use of any 
medications affecting blood lipid profile, glucose 
level, blood pressure (BP), and HR response to the 
exercise, such as digoxin, beta-blockers, or nondi-
hydropyridine calcium channel blockers, were also 
accepted as exclusion criteria. In addition, only the 
patients whose exercise tests had been terminated 
due to reached target HR were enrolled in this 
study. This study was designed as a retrospective 
study; the study protocol was prepared in accor-
dance with the Declaration of Helsinki and was 
approved by the local Ethic Committee.
Medical examination
Seated BP was measured 3 times after 
a 5-minute resting with the average of the last 
2 measurements. Height and weight values 
were measured with the participants in light 
examination clothes without shoes. Waist cir-
cumference was measured using the average of 
2 measurements between the iliac crest and the 
bottom of the ribcage while the subject was stan-
ding. Body mass index (BMI) was defined as weight 
in kilograms divided by the square of height in 
meter. Blood sampling was taken after at least 12 h 
fasting. The level of total cholesterol, high-density 
lipoprotein cholesterol (HDL-C), low-density lipo-
protein cholesterol (LDL-C), triglycerides (TG), 
glucose, insulin, creatinine, and hemoglobin were 
measured by using routine laboratory techniques. 
Homeostasis model assessment index of insulin 
resistance (HOMA-R) was defined as fasting plas-
ma insulin [mu/L] × fasting glucose [mg/dL]/405 
by using the Matthews’s equation [14].
Definition of metabolic syndrome
We defined MS according to the definition of 
the Third Adult Treatment Panel (NCEP-ATP III) 
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if 3 or more of the following components were 
met: (1) fasting blood glucose level ≥ 110 mg/dL; 
(2) systolic BP ≥ 130 mm Hg or diastolic 
BP ≥ 85 mm Hg; (3) TG level ≥ 150 mg/dL; 
(4) HDL-C level £ 40 mg/dL in men or £ 50 mg/dL 
in women; and (5) waist circumference > 102 cm 
in men or > 88 cm in women.
Protocol of the exercise stress test
The patients underwent a standard symptom-
-limited, maximal-graded exercise treadmill test 
according to the standard Bruce protocol with 
a Quinton Treadmill system (Quinton. Inc., Bothell, 
WA, USA). Continuous, 12-lead electrocardiogra-
phic monitoring was performed throughout the tes-
ting. The Tango exercise BP monitoring (SunTech 
Medical, Morrisville, North Carolina) device was 
used to automatically measure the subjects’ BP 
and HR before and at the second minute of each 
stage of the exercise. The participants exercised 
until limiting symptoms such as dyspnea, dizziness, 
fatigue, leg cramps, or if the HR achieved was more 
than > 95% of estimated maximal HR (220 – age). 
The patients continued to walk for 60 s at a speed 
of 1.5 mph during the recovery period and they 
sat down with continued BP and HR monitoring. 
HRR values were calculated by subtracting the HR 
at the first, second, third, and fourth minutes of 
the recovery period from the HR reached at peak 
exercise. The exercise capacity was calculated as 
total metabolic equivalent units (METs) achieved 
at peak exercise. HR was measured at rest, during 
each minute of exercise, and at the first, second, 
and third minutes of the recovery period.
Evaluation of the coronary blood flow
Coronary flow was evaluated objectively by 
2 independent observers using the TIMI frame 
count. TIMI frame count was determined for each 
major coronary artery in each subject according to 
the method first described by Gibson et al. [13]. 
The first frame was defined as the frame in which 
the full width of the proximal coronary artery lu-
men was filled with the concentrated dye, touching 
both borders of the lumen, and forward motion 
down the artery. The final frame was determined 
when the leading edge of the contrast column 
initially arrived at the distal landmark. The most 
distal branch nearest the apex of the left ventricle 
was used for the left anterior descending coronary 
artery (LAD), because the LAD is usually longer 
than the other major coronary arteries and the 
TIMI frame count for this vessel is often higher. 
Therefore, TIMI frame count was divided by 1.7 to 
obtain a corrected TIMI frame count for the LAD 
[13]. The distal landmark for the right coronary 
artery (RCA) was designated as the first branch 
of the posterolateral RCA after the origin of the 
posterior descending artery. The branch of the 
left circumflex artery (LCx) that encompassed the 
greatest total distance traveled by the contrast was 
used to define the distal landmark of the LCx. While 
the TIMI frame counts in the LAD and LCx were 
assessed in a right anterior oblique projection with 
caudal angulation, the RCA was assessed in a left 
anterior oblique projection with cranial angulation. 
The mean TIMI frame count for the individuals 
was calculated by adding the TIMI frame counts 
for the LAD, LCx, and RCA and then dividing the 
obtained value by 3.
Statistical analysis
While continuous variables were expressed as 
mean ± standard deviation, categorical variables 
were expressed as percentages. Comparisons 
of categorical and continuous variables between 
the two groups were performed using the c2 test 
and unpaired t-test, respectively. The correlation 
between biochemical, anthropometric measure-
ments, HRR values, and mean TIMI frame count 
was evaluated by the Pearson correlation test. 
Interobserver variability was determined by cal-
culating the differences between the means of the 
2 measurements made by 2 independent observers 
in the same patient. Measurement differences were 
converted into percentage differences, calculated 
as the difference between the measurements by 
the 2 observers divided by the average of the 
2 measurements multiplied by 100. Multivariate 
linear regression analysis was applied to evaluate 
the effects of mean TIMI frame count value and 
each of the MS components on HRR. A p value 
of < 0.05 was regarded as statistically significant. 
The SPSS (SPSS Inc., Chicago, IL, USA) version 
17.0 statistical package was used for all analyses.
Results
Baseline clinical characteristics of patients with 
MS and control patients are presented in Table 1. 
Patients with MS had higher systolic and diastolic 
BP, BMI, waist circumference, serum TG, and fas-
ting plasma glucose and lower HDL-C compared to 
control subjects, as expected. METs value (9.4 ± 
± 3.3 vs. 11.9 ± 2.7; p = 0.02) was significantly 
lower in patients with MS, as well. However, we 
found no significant difference between the two 
groups in respect to age, the status of cigarette 
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smoking, total cholesterol, hemoglobin, creatinine, 
and HOMA-R (Table 1).
All HRR values calculated at the first, second, 
third, and fourth minutes were detected significantly 
lower in the MS group compared to the control group 
(HRR 1st: 32 ± 9 vs. 37 ± 10; p = 0.01, HRR 2nd: 46 ± 11 
vs. 52 ± 11; p = 0.03, HRR 3rd: 51 ± 12 vs. 59 ± 12; 
p = 0.00, HRR 4th: 54 ± 13 vs. 61 ± 2; p = 0.02) 
(Table 2). The interobserver variability for the TIMI 
frame count measurement was 8%. The TIMI frame 
counts for each major epicardial coronary artery and 
mean TIMI frame count were found to be significantly 
higher in the MS group compared to the control group 
(LAD: 51 ± 24 vs. 39 ± 15; p = 0.009, LCx: 32 ± 11 
vs. 24 ± 7; p = 0.001, RCA: 33 ± 14 vs. 24 ± 10; 
p = 0.003, mean TIMI frame count: 38 ± 15 vs. 29 ± 9; 
p = 0.002) (Table 2). In addition, the TIMI frame 
counts for all three major coronary vessels were 
found to be significantly correlated with each other. 
Significant negative correlations were also detected 
between HRR 1st minute and coronary TIMI frame 
count values in patients with MS (Table 3, Fig. 1).
The results of multivariate linear regression 
analysis showed that none of MS parameters affec-
ted the HRR values, however mean TIMI frame 
count independently associated with the HRR 
Table 2. Comparison of the heart rate recovery (HRR) and the Thrombolysis in Myocardial Infarction 
(TIMI) frame counts values between two groups.
Control  
group (n = 37)
Metabolic syndrome  
group (n = 43)
P 
HRR 1st min [bpm] 37 ± 10 32 ± 9 0.01
HRR 2nd min [bpm] 52 ± 11 46 ± 11 0.03
HRR 3rd min [bpm] 59 ± 12 51 ± 12 0.00
HRR 4th min [bpm] 61 ± 2 54 ± 13 0.02
Left anterior descending coronary artery 39 ± 15 51 ± 24 0.009
Left circumflex coronary artery 24 ± 7 32 ± 11 0.001
Right coronary artery 24 ± 10 33 ± 14 0.003
Mean TIMI frame count 29 ± 9 38 ± 15 0.002
Table 1. Demographic and laboratory findings of the patients with metabolic syndrome (MS) and the 
controls.
Control group (n = 37) MS group (n = 43) P 
Age 51 ± 8 55 ± 10 0.68
Gender (male/female) 22 (59%)/15 (41%) 22 (51%)/21 (49%) 0.34
Smoking 19/18 (51%) 16/27 (37%) 0.14
Body mass index 27 ± 2 30 ± 3 0.00
Waist circumference [cm] 89 ± 8 100 ± 8 0.00
Systolic blood pressure [mm/Hg] 128 ± 25 141 ± 20 0.01
Diastolic blood pressure [mm/Hg] 77 ± 12 82 ± 13 0.05
Resting heart rate [bpm] 74 ± 13 78 ± 13 0.19
Peak exercise herat rate [bpm] 158 ± 17 151 ± 18 0.10
Exercise capacity [METs] 11.9 ± 2.7 9.4 ± 3.3 0.02
Fasting glucose [mg/dL] 97 ± 13 115 ± 29 0.01
Total cholesterol [mg/dL] 204 ± 49 188 ± 44 0.13
LDL cholesterol [mg/dL] 137 ± 42 129 ± 32 0.36
HDL cholesterol [mg/dL] 44 ± 12 35 ± 7 0.01
Triglyceride [mg/dL] 113 ± 33 157 ± 48 0.06
Hemoglobin [g/dL] 14 ± 1 14 ± 1 0.71
Creatinine [mg/dL] 0.8 ± 0.1 0.8 ± 0.1 0.18
Insulin resistance (HOMA-R) 2.3 ± 1.8 3.5 ± 2.1 0.13
LDL — low density lipoprotein; HDL — high density lipoprotein; METs — metabolic equivalent units
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Figure 1A–D. Significant negative correlations between heart rate recovery (HRR) 1st minute and coronary Throm-
bolysis in Myocardial Infarction (TIMI) frame count values in patients with metabolic syndrome (MS) (squares: MS, 
circles: non-MS); LAD — left anterior descending coronary artery; LCx — left circumflex coronary artery; RCA — right 
coronary artery.
Table 3. Correlations between heart rate recovery (HRR) 1st minute and coronary Thrombolysis in  
Myocardial Infarction (TIMI) frame count values in patients with metabolic syndrome.
HRR 1st minute 
Correlation coefficients (r) P 
Left anterior descending coronary artery –0.33 0.02
Left circumflex coronary artery –0.34 0.02
Right coronary artery –0.38 0.01
Mean TIMI frame count –0.38 0.01
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1st minute (r: –0.27, p = 0.04) in patients with 
MS. On the other hand, neither MS parameters 
nor mean frame count affected any HRR values in 
the control group at a statistically significant level 
(Table 4).
Discussion
In the literature, decreased HRR values are 
mostly demonstrated for the first, second, and, 
rarely, third minutes of the recovery period after 
exercise testing. In this study, we calculated HRR 
values at first, second, third, and fourth minutes 
during the recovery period after a maximal exer-
cise test. The results obtained in this study are as 
follows. First, we determined that all HRR values 
calculated were impaired in patients with MS com-
pared to an age and sex matched control group who 
did not meet the diagnostic criteria for MS. Second, 
the TIMI frame counts for each major epicardial 
coronary artery and mean TIMI frame count were 
found to be significantly higher in the MS group 
compared to the controls. Third, a significant 
negative correlation was also detected between 
mean TIMI frame count and HRR 1st minute in 
patients with MS. And finally, we also found that 
mean TIMI frame count was the only independent 
predictor of decreased HRR in patients with MS. 
To our knowledge, this is the first study indicating 
this association between mean TIMI frame count 
and HRR in MS patients. This finding, in addition 
to the decreased HRR values, may especially 
help to identify the patients who have potentially 
increased CV risk despite having angiographically 
proven normal coronary arteries.
The association between MS and increased 
risk for CV disease has been well established in the 
previous studies [15–18]. It was determined that 
MS has added significant prognostic information to 
the established risk factors for CV disease, such as 
smoking, diabetes, hypertension, and hyperlipide-
mia [19]. Slow deceleration of HR after exercise 
was shown to indicate autonomic dysfunction [20] 
and was found to be an independent predictor of 
CV disease and all-cause mortality [3, 4]. This 
autonomic dysfunction, including impaired vagal 
reactivation, as well as sympathetic overactivity, 
is known to be associated with hyperinsulinemia 
or insulin resistance, which determines MS [5–7]. 
Exercise capacity and HRR were detected to be sig - 
nificantly impaired in young adult males with MS, 
by Deniz et al. [21]. It was indicated in the literatu-
re that exercise training induced favorable changes 
in HRR in obese men with MS [22], while reduced 
exercise capacity was related to cardiometabolic 
risk factors even in young populations [23]. Fur-
thermore, it was shown that there was a relationship 
between MS and cardiac autonomic dysfunction, as 
detected by HR turbulence in non-diabetic patients 
[24]. Epicardial fat tissue is known to have unique 
endocrine and paracrine functions, and impairs 
the cardiac autonomic system, so its thickness 
was shown to be associated with blunted HRR in 
patients with MS [25]. It was also determined that 
decreased HRR was independently associated with 
MS after adjustment for the resting HR [9]. In our 
study as well, we detected that exercise capacity 
was lower in patients with MS than in the control 
group, however, there was no significant difference 
between the two groups in terms of both baseline 
and peak exercise HR values.
An impaired HRR at the first minute after 
graded exercise has been shown to be a power-
ful predictor of overall mortality, independent of 
workload, changes in HR during exercise, and 
the presence or absence of myocardial perfusion 
defects [8]. It was suggested in another study that 
decreased HRR occurred after, but not before, the 
presence of MS [26]. It was thought that decreased 
HRR in the presence of MS components is one 
Table 4. Role of mean Thrombolysis in Myocardial Infarction (TIMI) frame count and each of the para-
meters of metabolic syndrome (MS) on heart rate recovery 1st minute in two groups.
Control group
Coefficients (r)
P MS group
Coefficients (r)
P
Mean TIMI frame count –0.02 0.9 –0.27 0.04
Waist circumference [cm] –0.14 0.5 –0.33 0.85
Systolic blood pressure [mm Hg] –0.17 0.08 –0.10 0.17
Diastolic blood pressure [mm Hg] 0.36 0.08 0.18 0.17
Fasting glucose [mg/dL] –0.15 0.27 –0.03 0.96
High density lipoprotein cholesterol [mg/dL] 0.25 0.83 1.7 0.40
Triglyceride [mg/dL] 0.02 0.9 0.39 0.35
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possible mechanism by which MS is associated 
with increased CV disease morbidity and mortality 
[27]. In several studies, HRR has also been found 
to be associated with individual components of 
MS, such as blood glucose [9, 28], low HDL-C [8, 
9], and resting systolic and diastolic BP [9]. In our 
study, we found such an association between HRR 
and fasting glucose and systolic BP values.
It is well known that endothelium plays an 
important role in the control of coronary blood flow 
by regulating coronary vascular resistance. Several 
CV risk factors associated with insulin resistance, 
comprising the MS, may be accompanied by endo-
thelial dysfunction even in morphologically intact 
vessels before the onset of clinically manifested 
vascular disease [10, 11]. Coronary microvascu-
lature are the major source of coronary vascular 
resistance due to their small diameters and well-
-developed media [29]. It was stipulated in a study 
that the presence of increased TIMI frame counts 
in patients with MS with angiographically proven 
normal coronary arteries may be the result of 
impaired vessel function indicating microvascu-
lar dysfunction [12]. The effect of the autonomic 
nervous system on coronary blood flow and insulin 
resistance is well known; however, it has not been 
exactly understood yet whether impaired coronary 
blood flow occurring in MS arises from endothelial 
dysfunction or autonomic dysfunction.
Limitations of the study
The main limitations of this study are the 
small number of subjects and also its retrospective 
nature. The next limitation of our study is that the 
angiographic definition of normal coronary arteries 
depends on contrast angiograms of the vessel 
lumen, which may underestimate the presence of 
atherosclerotic plaque [30]. The atherosclerosis, 
which is associated with medial atrophy and ves-
sel wall dilatation resulting in diffusely diseased 
coronary arteries, may not be visualized in normal 
coronary angiography [31]. Some new imaging 
modalities, such as intravascular ultrasound and 
optical coherence tomography, overcome the li-
mitation of angiography with tomographic images 
that provide an accurate characterization of vessel 
lumen and wall geometry as well as the presence 
and distribution of atherosclerosis.
Conclusions
We have shown in our study that the TIMI fra-
me counts for each major epicardial coronary artery 
and mean TIMI frame count indicating impaired 
coronary blood flow and all HRR values calculated 
indicating autonomic dysfunction were significantly 
higher in the MS group compared to the control 
group, a population that consists of the participants 
with angiographically normal coronary arteries. 
This angiographic finding might be considered 
a sign of coronary microvascular endothelial dys-
function in patients with MS. We have also detected, 
for the first time in the literature, that there was 
a significant negative correlation between mean 
TIMI frame count and HRR 1st minute, and that 
mean TIMI frame count was the only parameter 
independently associated with the HRR 1st minute 
in patients with MS. Therefore, impaired coronary 
blood flow occurring in MS might be a clue of the 
autonomic dysfunction in addition to endothelial 
dysfunction. We believe that this significant asso-
ciation between mean TIMI frame count and HRR, 
in addition to reduced HRR, may be used as an 
early marker for increased CV morbidity and mor-
tality in these subjects and thus would have a high 
value in the subsequent guidance of the diagnosis 
and treatment. However, further research with 
a greater patient population is needed to show the 
reliability of this association.
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